Atlas Trials

Evaluation of ProALL miRs in Blood Specimen for Prediction of ALL Relapse Risk

Clinical trial NCT03000335 · UNKNOWN

Trial details

NCT number
NCT03000335
Sponsor
Curewize Health Ltd.
Status
UNKNOWN
Study type
OBSERVATIONAL
B-cell Acute Lymphoblastic Leukemia
Start date
2016-12-01
Primary completion
2020-05-01
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.